trending Market Intelligence /marketintelligence/en/news-insights/trending/Eff-47tNxhILgg6Yr1JYwg2 content
Log in to other products

Login to Market Intelligence Platform

 /


Looking for more?

Contact Us

Request a Demo

You're one step closer to unlocking our suite of comprehensive and robust tools.

Fill out the form so we can connect you to the right person.

If your company has a current subscription with S&P Global Market Intelligence, you can register as a new user for access to the platform(s) covered by your license at Market Intelligence platform or S&P Capital IQ.

  • First Name*
  • Last Name*
  • Business Email *
  • Phone *
  • Company Name *
  • City *
  • We generated a verification code for you

  • Enter verification Code here*

* Required

In this list

Titan Medical closes US$25M offering of shares, warrants

Gauging Supply Chain Risk In Volatile Times

S&P Global Market Intelligence

Cannabis: Hashing Out a Budding Industry

Segment

IFRS 9 Impairment How It Impacts Your Corporation And How We Can Help

The Market Intelligence Platform


Titan Medical closes US$25M offering of shares, warrants

Titan Medical Inc. closed an underwritten public offering of units, raising gross proceeds of about US$25 million.

The Toronto-based medical device company sold 7,352,941 units, priced US$3.40 apiece.

Each unit included one common share and one warrant to buy one common share at US$4 until expiry on March 20, 2024.

The transaction agent fully exercised the option to buy an additional 1,102,941 units at the offering price, for additional gross proceeds of US$3.8 million.

Shares sold and issued were listed on the Toronto Stock Exchange under the symbol TMD and on the Nasdaq Capital Market under the symbol TMDI.

Proceeds will go toward developing Titan's Sport Surgical System, working capital and other general corporate purposes.

Bloom Burton Securities Inc. was the agent for the transaction and appointed Northland Capital Markets, a division of Northland Securities Inc., as sub-agent.

Titan Medical develops and sells computer-assisted robotic surgical technologies for use in minimally invasive surgery.